Showing results (471-480 of 674) with videos related to

Sort By:
Pageof 68
Intestinal Research|December 5, 2025
Comparison between endoscopic resection and transanal surgery for treatment of rectal tumors: a systematic review and meta‑analysisChan Hyuk Park, Byung Wook Jung, Yoon Suk Jung
Intestinal Research|December 3, 2025
Effectiveness, safety, and pharmacokinetics of the infliximab biosimilar CT-P13 after non-medical switch from the infliximab originator in patients with inflammatory bowel diseaseRyohei Nomaru, Teruyuki Takeda, Atsushi Takahashi, et al.
Intestinal Research|November 14, 2025
The impact of inflammatory bowel disease on women's health: a cross sectional study in IndiaArshia Bhardwaj, Arshdeep Singh, Riya Sharma, et al.
Intestinal Research|December 12, 2025
Fecal surrogate markers strongly correlate with endoscopic findings in pediatric onset inflammatory bowel disease: a retrospective study in JapanRyoko Yoshimura, Takahiro Kudo, Masanori Toda, et al.
Intestinal Research|November 6, 2025
Knowledge and acceptability of the Lémann Index as a tool to measure disease progression and bowel damage in Crohn's disease: results from an international surveyCharlotte Wong, Johan Burisch, Ryan C Ungaro, et al.
Intestinal Research|June 23, 2025
A real-world comparison of subcutaneous to intravenous administration of infliximab in patients with inflammatory bowel diseaseKwang Woo Kim, Hyoun Woo Kang, Seong-Joon Koh, et al.
Intestinal Research|May 14, 2025
Lifestyle restrictions are associated with impaired quality of life but not reduction in relapse in ulcerative colitisHajime Yamazaki, Masakazu Nagahori, Tadakazu Hisamatsu, et al.
Intestinal Research|April 25, 2025
Clinical characteristics of patients with difficult-to-treat ulcerative colitis: a nested case-control study using a Japanese claims databaseKatsuyoshi Matsuoka, Ataru Igarashi, Noriko Sato, et al.
Intestinal Research|September 29, 2025
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world studyAntonio Tursi, Giammarco Mocci, Francesco Costa, et al.
Intestinal Research|February 9, 2026
First-line biologic therapy selection highly impacts ulcerative colitis outcomes: results from the APPETISER studyDiari M'Baye, Marianne Hupé, Marie Dodel, et al.
Pageof 68